Cardiol Therapeutics (CRTPF) News Today $0.97 +0.01 (+1.02%) As of 03/31/2025 Add Compare Share Share Headlines Stock AnalysisChartBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Cardiol Therapeutics Inc.: Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care ConferenceMarch 3, 2025 | finanznachrichten.deCardiol Therapeutics’ CardiolRx Gains Buy Rating on Positive Phase 2 Results and Strong Financial PositionNovember 21, 2024 | markets.businessinsider.comCardiol Therapeutics Faces Rising Losses and Falling AssetsNovember 16, 2024 | markets.businessinsider.comInside the production pipeline for new drugs to combat heart failureSeptember 14, 2024 | msn.comCardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart DiseaseAugust 22, 2024 | seekingalpha.comCardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of PericarditisFebruary 15, 2024 | finance.yahoo.comCardiol Therapeutics Fights Heart Inflammation With Novel FormulationsOctober 12, 2023 | benzinga.comCardiol Therapeutics Inc. (CRDL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?September 13, 2023 | finance.yahoo.comClosing Bell: Cardiol Therapeutics Inc flat on Friday (CRDL)August 26, 2023 | theglobeandmail.comCardiol Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (CRDL)August 18, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc flat on Monday (CRDL)August 14, 2023 | theglobeandmail.comCardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital MarketAugust 8, 2023 | finance.yahoo.comClosing Bell: Cardiol Therapeutics Inc up on Thursday (CRDL)April 20, 2023 | theglobeandmail.comHere's Why Cardiol Therapeutics Inc. (CRDL) Could be Great Choice for a Bottom FisherNovember 11, 2022 | nasdaq.comCardiol Therapeutics Inc. (CRDL)September 24, 2022 | uk.finance.yahoo.comCardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of DirectorsMay 19, 2022 | stockhouse.comCardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory BoardJanuary 19, 2022 | finance.yahoo.comCardiol Therapeutics Inc - Class A Shares Close the Day 16.3% Higher - Daily WrapJanuary 16, 2022 | nasdaq.comCardiol Therapeutics IncNovember 3, 2021 | reuters.comCardiol Therapeutics Shares Drop After Unit Offering PricesNovember 3, 2021 | marketwatch.comCardiol Therapeutics Inc. (CRDL) Could Find Support Soon, Here's Why You Should Buy the Stock NowOctober 26, 2021 | nasdaq.comCardiol Therapeutics Expanding LANCER Trial, Shares Trading HigherOctober 18, 2021 | marketwatch.comWhen Will Cardiol Therapeutics Inc. (TSE:CRDL) Turn A Profit?August 19, 2021 | finance.yahoo.comBRIEF-Cardiol Therapeutics To Commence Trading On Nasdaq Under Symbol "CRDL"August 9, 2021 | msn.comCardiol Therapeutics receives final approval to list its common...August 9, 2021 | proactiveinvestors.comCardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol "CRDL"August 9, 2021 | finance.yahoo.comCardiol Therapeutics Inc.August 6, 2021 | barrons.com Remove Ads Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTPF and its competitors with MarketBeat's FREE daily newsletter. Email Address CRTPF Media Mentions By Week CRTPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRTPF News Sentiment▼0.000.78▲Average Medical News Sentiment CRTPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRTPF Articles This Week▼00▲CRTPF Articles Average Week Remove Ads Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Algernon Pharmaceuticals News Allstar Health Brands News Anew Medical News Arno Therapeutics News AstraZeneca News AVAX Technologies News AVVAA World Health Care Products News BriaCell Therapeutics News Cannabis Global News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CRTPF) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
